Sign inGet started

Martell Christopher

Insider CIK 1873465 · CADL Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CADL Candel Therapeutics, Inc. A Award deriv2026-06-232026-06-2432,000— $032,000SEC↗
CADL Candel Therapeutics, Inc. A Award2025-06-252025-06-26111,349$4.67 $520.0K111,349SEC↗
CADL Candel Therapeutics, Inc. A Award deriv2025-06-172025-06-1814,240— $014,240SEC↗
CADL Candel Therapeutics, Inc. A Award deriv2024-06-262024-06-2714,240— $014,240SEC↗
CADL Candel Therapeutics, Inc. A Award deriv2023-06-282023-06-2914,240— $014,240SEC↗
CADL Candel Therapeutics, Inc. P Buy2022-12-092023-02-1723,950$1.92 $46.0K152,000SEC↗
CADL Candel Therapeutics, Inc. P Buy2022-12-092022-12-1223,950$1.92 $46.0K152,000SEC↗
CADL Candel Therapeutics, Inc. P Buy2022-12-082023-02-173,050$1.68 $5.1K128,050SEC↗
CADL Candel Therapeutics, Inc. P Buy2022-12-082022-12-123,050$1.68 $5.1K128,050SEC↗
CADL Candel Therapeutics, Inc. A Award deriv2022-10-132022-10-1714,240— $014,240SEC↗
CADL Candel Therapeutics, Inc. C Conversion deriv2021-07-292021-08-02696,851— $00SEC↗
CADL Candel Therapeutics, Inc. P Buy2021-07-292021-08-02125,000$8.00 $1.00M125,000SEC↗
CADL Candel Therapeutics, Inc. C Conversion2021-07-292021-08-02283,514— $0283,514SEC↗